Sinovac Phase 3 Trial Results Expected Next Week

"); jQuery("#212 h3").html("

Related News Programmes

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1565715_1_20201217054113.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1565715-20201217.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1565715-20201217.htm', 'DCS.dcsqry', '' ); } } }); }); });

2020-12-17 HKT 05:38

Share this story

facebook

  • The government announced last week that it has secured 7.5 million doses from the mainland firm. Photo: Shutterstock

    The government announced last week that it has secured 7.5 million doses from the mainland firm. Photo: Shutterstock

Government adviser and respiratory medicine expert Dr David Hui said on Wednesday that he expected the phase 3 clinical trial results of the Sinovac coronavirus vaccine to be out on December 23.

The government announced last week that it had secured 7.5 million doses from the mainland firm as part of its procurement programme.

Dr Hui said if there were no problems with the trial results, the vaccine could be introduced here next month.

"At the moment Sinovac has published phase 1 and phase 2 data, showing the antibodies can develop in over 90 percent of the recipients," he said.

Dr Hui said that only when the company had good data would the vaccine be introduced in Hong Kong.

The government is making arrangements for three vaccines: Sinovac, Fosun BioNTech and Astrazeneca.

Dr Hui said the public wouldn't get to choose which vaccine they would get because this could lead to a shortage of one type of vaccine and a surplus of another.

He said any vaccine that was in surplus might therefore end up being wasted, as they have a shelf-life of about six months.

RECENT NEWS

Treasury Secretary Grilled On Economic Figures And Foreign Policy. He Refrained From Directly Calling Ukraine An Ally.

Treasury Secretary Scott Bessent emphasized that prices would come down as soon as the Iran war ended, hailed Trump's ec... Read more

More Than Seven In Ten Americans Think The U.S. Is On The 'Wrong Track' Ahead Of The Midterms: Poll

The new poll also showed that Trump's approval rating had sunk to 34%, with more than half of respondents saying they "s... Read more

World Bank Encourages Developing Nations To Embrace 'Small' AI To Accelerate Economic Growth

Paschal Donohoe, the managing director and chief knowledge officer at the World Bank, said that so-called "small AI" cou... Read more

Ukraine Launches Large-Scale Drone Attack On Russia, Defies Trump's Demands To Leave Russian Energy Alone

Swarms of Ukrainian drones hit numerous targets in Russia, including an oil terminal, overnight despite Trump's repeated... Read more

Protests In France Are Becoming Increasingly Violent. Demonstrations Have Now Spread To Other European Countries.

The protests, which began as localized demonstrations against perceived neglect in the French education system, intensif... Read more

Trump Maintains Defiant Message In Kentucky Midterm Rally, Makes Dubious Claims About Republican Popularity

The president held a rally on Saturday in which he touted the supposed successes of his two terms in office, attacked hi... Read more